Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU
<a href="https://pixabay.com/users/fernandozhiminaicela/">fernandozhiminaicela</a> / Pixabay

Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU

According to a story from Market Screener, the specialty pharmaceutical company Santhera Pharmaceuticals recently released an announcement in which the company revealed its intent to file for Conditional Marketing Authorization…

Continue Reading

The Struggles of being a Rare Disease Patient in China

The State of Rare Diseases in China The Illness Challenge Foundation (ICF) is an organization devoted to easing the burdens that rare disease patients living in China face. They accomplish this…

Continue Reading
Close Menu